Nissan Medical Industries Ltd (NISA.TA)
ILA 1371.0
(-3.92%)
ILA 1371.0
(-3.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 105.71 Million | 11.67 Million | 17.97 Million | 122.56 Million | 55.76 Million | 85.83 Million |
| Net Income | 19.04 Million | -47.28 Million | 57.15 Million | 92.88 Million | 25.57 Million | 40.41 Million |
| Depreciation & Amortization | 31.14 Million | 28.65 Million | 25.59 Million | 27.41 Million | 28.69 Million | 26.18 Million |
| Deferred income taxes | 6.29 Million | -2.79 Million | -8.38 Million | -1.91 Million | -2.76 Million | 2.98 Million |
| Stock-based compensation | 578 Thousand | 270 Thousand | 1.44 Million | 3.02 Million | 700 Thousand | 1.43 Million |
| Change in working capital | 27.01 Million | -9.23 Million | -61.02 Million | -5.54 Million | -6.27 Million | 2.69 Million |
| Other non-cash items | 21.64 Million | 42.06 Million | 3.19 Million | 6.69 Million | 9.83 Million | 12.11 Million |
| Investing Cash Flow | -9.92 Million | -9.67 Million | 5.62 Million | -12.42 Million | -6.92 Million | -9.93 Million |
| Investments in PPE | -10.18 Million | -9.69 Million | -8.3 Million | -13.9 Million | -10.2 Million | -11.98 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -150 Thousand | - | - | - | - |
| Sales/Maturities of investments | - | - | 8.42 Million | 591 Thousand | 2.41 Million | 1.07 Million |
| Other Investing Activities | 255 Thousand | 165 Thousand | 5.5 Million | 898 Thousand | 867 Thousand | 978 Thousand |
| Financing Cash Flow | -90.71 Million | -25.78 Million | -31.19 Million | -80.26 Million | -40.33 Million | -76.27 Million |
| Debt repayment | -67.34 Million | -62.68 Million | -80.37 Million | -75.77 Million | -91.72 Million | -100.01 Million |
| Dividends payments | - | -3.99 Million | -9.08 Million | -9.99 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -23.36 Million | 40.89 Million | 58.26 Million | 5.5 Million | 51.38 Million | 23.74 Million |
| Accounts receivables | 33.79 Million | -19.71 Million | -16.44 Million | -21.88 Million | 3.27 Million | 2.95 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -6.06 Million | 8.4 Million | -51.99 Million | 9.37 Million | 8.58 Million | -14.39 Million |
| Other working capital | 33.08 Million | -17.64 Million | -9.03 Million | -14.91 Million | -14.86 Million | 17.08 Million |
| Cash at beginning of period | 19.33 Million | 40.08 Million | 48.55 Million | 21.54 Million | 14.32 Million | 13.69 Million |
| Cash at end of period | 24.86 Million | 19.33 Million | 40.08 Million | 48.55 Million | 21.54 Million | 14.32 Million |
| Capital Expenditure | -10.18 Million | -9.69 Million | -8.3 Million | -13.9 Million | -10.2 Million | -11.98 Million |
| Effect of forex changes on cash | 455 Thousand | 3.03 Million | -880 Thousand | -2.87 Million | -1.28 Million | 1 Million |
| Net cash flow / Change in cash | 5.53 Million | -20.75 Million | -8.47 Million | 27.01 Million | 7.21 Million | 634 Thousand |
| Free Cash Flow | 95.53 Million | 1.98 Million | 9.67 Million | 108.66 Million | 45.56 Million | 73.85 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.47 Million | 14.98 Million | 19.04 Million | 15.25 Million | 3.78 Million | 4.41 Million |
| Depreciation & Amortization | 7.64 Million | 6.9 Million | 31.14 Million | 7.87 Million | 7.74 Million | 7.88 Million |
| Deferred income taxes | - | - | 6.29 Million | 2.42 Million | 3.37 Million | -2.91 Million |
| Stock-based compensation | 352 Thousand | 344 Thousand | 578 Thousand | 388 Thousand | 139 Thousand | 29 Thousand |
| Change in working capital | -30.28 Million | 2.61 Million | 27.01 Million | 10.8 Million | -13.17 Million | 2.59 Million |
| Other non-cash items | 3.41 Million | 4.23 Million | 21.64 Million | 2.84 Million | 6.74 Million | 5.72 Million |
| Investing Cash Flow | -871 Thousand | -1.31 Million | -9.92 Million | -4.02 Million | -1.29 Million | -2.1 Million |
| Investments in PPE | -1.05 Million | -1.26 Million | -10.18 Million | -4.04 Million | -1.36 Million | -2.1 Million |
| Acquisitions | - | 15.16 Million | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 158 Thousand | - | - | - | - | - |
| Other Investing Activities | 157.99 Thousand | -1.49 Million | 255 Thousand | 18 Thousand | 69 Thousand | -35 Thousand |
| Financing Cash Flow | 4.81 Million | -29.9 Million | -90.71 Million | -32.36 Million | -15.14 Million | -19.29 Million |
| Debt repayment | -9.89 Million | -24.63 Million | -67.34 Million | -22.55 Million | -14.87 Million | -14.93 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -846 Thousand | -14.28 Million | -23.36 Million | -9.81 Million | -276 Thousand | -4.35 Million |
| Accounts receivables | -2.39 Million | -7.41 Million | 33.79 Million | 15.32 Million | 9.83 Million | 6.89 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | -25.9 Million | 1.45 Million | -6.06 Million | 10.67 Million | -34.23 Million | 8.09 Million |
| Other working capital | -2.66 Million | 2.69 Million | 33.08 Million | 132 Thousand | 21.06 Million | -5.5 Million |
| Cash at beginning of period | 24.14 Million | 24.86 Million | 19.33 Million | 22.92 Million | 30.27 Million | 33.48 Million |
| Cash at end of period | 11.37 Million | 24.14 Million | 24.86 Million | 24.86 Million | 22.92 Million | 30.27 Million |
| Capital Expenditure | -1.05 Million | -1.26 Million | -10.18 Million | -4.04 Million | -1.36 Million | -2.1 Million |
| Effect of forex changes on cash | 288 Thousand | 360 Thousand | 455 Thousand | -1.26 Million | 480 Thousand | 463 Thousand |
| Net cash flow / Change in cash | -12.77 Million | -712 Thousand | 5.53 Million | 1.93 Million | -7.34 Million | -3.21 Million |
| Free Cash Flow | -18.05 Million | 28.88 Million | 95.53 Million | 35.55 Million | 7.25 Million | 15.62 Million |
605337
LBRDK
DIFI
VET
SMFX
IDAI